Ready to play
Ready to play
Samarra Pharmaceuticals announced the production of the antibiotic Moxifloxacin for the first time as part of their local products. This broad-spectrum antibiotic is used to treat bacterial infections such as pneumonia, sinusitis, and skin and soft tissue infections. The goal of this achievement is to reduce reliance on imported medicines, enhance pharmaceutical security, and support the localization of the domestic pharmaceutical industry.
Notice: This Is an AI-Generated Summary
Comments (0)